Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 12 May 2006. doi:10.1136/jcp.2005.035758
Journal of Clinical Pathology 2007;60:57-61
Copyright © 2007 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

ORIGINAL ARTICLE

Construction and validation of a bone marrow tissue microarray

Annette Zimpfer1, Sharon Schönberg1, Alessandro Lugli1, Claudio Agostinelli2, Stefano A Pileri2, Philip Went1 and Stephan Dirnhofer1

1 Institute of Pathology, University Hospital of Basel, Basel, Switzerland
2 Pathologic Anatomy & Haematopathology Unit, Institute of Haematology and Clinical Oncology "L. & A. Seràgnoli", University of Bologna, Bologna, Italy

Correspondence to:
Correspondence to:
Dr Stephan Dirnhofer
Institute of Pathology, University Hospital of Basel, Schönbeinstrasse 40, Basel CH-4031, Switzerland; sdirnhofer{at}uhbs.ch

Background: The use of tissue microarrays (TMAs) is now a generally accepted method for the investigation of solid tumours. However, little is known about the applicability of the TMA technique for analysis of patients with acute leukaemia. A bone marrow (BM)-TMA analysis with 15 different immunohistochemical markers was performed. The TMA was validated by comparison with the corresponding full tissue sections.

Materials and methods: A BM-TMA comprising 148 cases of acute leukaemia, including 115 acute myeloid leukaemia (AML) and 33 acute lymphoblastic leukaemia (ALL) cases, was constructed. Expression of CD3, CD10, CD15, CD20, CD34, CD61, CD68, CD79a, CD99, CD117, CD138, myeloperoxidase, haemoglobin A1, glycophorin and terminal deoxynucleotidyl transferase was immunohistochemically analysed. 50 cases of the TMA were directly compared with the corresponding full tissue section to validate the results.

Results: Morphologically and immunohistochemically, 6 (4%) of 148 cases and 765 (11%) cores of 6912 individual analyses were not evaluable. A direct comparison of TMA cases with conventional full sections showed a concordance of the results of 100%.

Conclusions: The small size of bone-marrow biopsies and the presence of bony trabeculae do not preclude construction and analysis of acute leukaemia TMAs. Acute leukaemia cases on TMA displayed the characteristic phenotypic profiles expected in different AML and ALL subtypes. Therefore, the TMA technique is also a promising method for high-throughput analysis of combined marker expression and clinicopathological correlations in patients with leukaemia.

Abbreviations: ALL, acute lymphoblastic leukaemia; AML, acute myeloid leukaemia; BM-TMA, bone marrow tissue microarray; cHL, classical Hodgkin’s lymphoma; FAB, French–American–British; GEP, gene expression profiling; H&E, haematoxylin and eosin; MPO, myeloperoxidase; TdT, terminal deoxynucleotidyl transferase; TMA, tissue microarray


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs